nach oben

Erschienen in:

25.06.2020 | Letter to the Editor

IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection

verfasst von: Carolina Villegas, María Poza, Paloma Talayero, José Manuel Caro Teller, Denis Zafra, Cristina Garcia, Elena Vera, Marta Hidalgo, Nieves Lopez, Clara Cuellar, Irene Zamanillo, Rodrigo Íñiguez, Estela Paz-Artal, José M. Aguado, J. Martinez-Lopez

Erschienen in: Annals of Hematology | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Excerpt

Coronavirus disease 2019 (COVID-19) has been confirmed in more than three million people worldwide. This infection can become serious in 20% of cases, with a mortality rate of 3–7%, much higher than that of influenza (1%) [1, 2]. Hematological patients are a vulnerable subpopulation due to altered immunity secondary to underlying disease and treatment. Clinical outcomes may be completely different from that of the general population. …

Nur mit Berechtigung zugänglich

Organization WH. 2020 Novel coronavirus–China. World Health Organization cited January 20

Center for Systems Science and Engineering. Coronavirus COVID-19 global cases.2019 (https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6. opens in new tab). 2020

Ruan Q, Yang K, Wang W, Jiang L, Song J (2020) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan. China. 46(5):846–848

Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, Cron RQ, Opal SM (2016) Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial. Crit Care Med 44:275–281CrossRef

Moore BJB, June CH (2020) Cytokine release syndrome in severe COVID-19. Science. 368:473–474CrossRef

Cavalli G, De Luca G, Campochiario C et al (2020) Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study (published online ahead of print 7 May 2020). Lancet Rheumatol. https://doi.org/10.1016/S2665-9913(20)30127-2

Xu X, Han M, Li T et al Effective treatment of severe COVID-19 patients with tocilizumab (published online ahead of print 29 April 2020). Proc Natl Acad Sci U S A. https://doi.org/10.12074/202003.00026

Dinarello CA (2018) Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev 281(1):8–27CrossRef

Schulert GS, Grom AA (2015) Pathogenesis of macrophage activation syndrome and potential for cytokine directed therapies. Annu Rev Med 66:145–159CrossRef

10.

Remy KE, Brakenridge SC, Francois B et al Immunotherapies for COVID-19: lessons learned from sepsis (published online ahead of print 28 April 2020). Lancet. https://doi.org/10.1016/S2213-2600(20)30217-4

Titel: IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection
verfasst von: Carolina Villegas
María Poza
Paloma Talayero
José Manuel Caro Teller
Denis Zafra
Cristina Garcia
Elena Vera
Marta Hidalgo
Nieves Lopez
Clara Cuellar
Irene Zamanillo
Rodrigo Íñiguez
Estela Paz-Artal
José M. Aguado
J. Martinez-Lopez
Publikationsdatum: 25.06.2020
Verlag: Springer Berlin Heidelberg
Erschienen in: Annals of Hematology / Ausgabe 12/2020
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-020-04160-w

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Costims – das nächste heiße Ding in der Krebstherapie?

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2020

Alloimmunization and autoimmunization in adult transfusion-dependent thalassemia patients: a report from a comprehensive center in Israel

Rare synchronous co-existence of acute myeloid leukemia and hairy cell leukemia in a same patient

Venetoclax monotherapy for cutaneous blastic plasmacytoid dendritic cell neoplasm

Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia

Effect of allogeneic HCT from unrelated donors in AML patients with intermediate- or poor-risk cytogenetics: a retrospective study from the Japanese Society for HCT

Living donor kidney transplantation is an effective option of renal replacement therapy in patients with light-chain amyloidosis (AL)

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Costims – das nächste heiße Ding in der Krebstherapie?

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

Update Innere Medizin